Insider · CIK 0001814238
Christopher Hite
chairofficer
Files at RPRX (Royalty Pharma plc). First filing Sep 24, 2026, latest Sep 24, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $5.9M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RPRX: Royalty Pharma plc
RPRXOct 9, 2026 · close 56.93
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Royalty Pharma plc | $5.9M 100,000 shares | -27% | +71% from low-9% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | RPRX Royalty Pharma plc | SOpen-market sale Class A Ordinary Sharesindirect: By SCH Investment Partners LLC10b5-1 | -96,073 | $58.51 | $5.6M | 274,328 | 18 d ago |
| Sep 22, 2026 | RPRX Royalty Pharma plc | SOpen-market sale Class A Ordinary Sharesindirect: By SCH Investment Partners LLC10b5-1 | -3,927 | $58.93 | $231k | 270,401 | 18 d ago |
| Aug 6, 2025 | RPRX Royalty Pharma plc | AGrant or award Class A Ordinary Sharesindirect: By SCH Investment Partners LLC | +3,696 | $0.00 | $0 | 652,342 | Aug 8, 2025 |
| May 16, 2025 | RPRX Royalty Pharma plc | AGrant or award Class E Ordinary Sharesderivativeindirect: See Footnote (1)(2) | +1,238,789 | $0.00 | $0 | 1,238,789 | May 20, 2025 |
| May 8, 2025 | RPRX Royalty Pharma plc | AGrant or award Class A Ordinary Sharesindirect: By SCH Investment Partners LLC | +48,646 | $0.00 | $0 | 648,646 | May 9, 2025 |
| Feb 14, 2025 | RPRX Royalty Pharma plc | CConversion Class A Ordinary Sharesindirect: By SCH Investment Partners LLC | +300,000 | $0.00 | $0 | 600,000 | Feb 18, 2025 |
| Feb 14, 2025 | RPRX Royalty Pharma plc | CConversion LP interests in RPI US Partners 2019, LPderivativeindirect: By SCH Investment Partners LLC | -30,000 | $0.00 | $0 | 86,641 | Feb 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.